Expo-certificate. Vittamed has successfully finished project "Products certification for export markets" funded by European Union structural funds programme "EXPO certificate" and administered by Lithuanian Business Support Agency.
E-business. Vittamed has started implementing project "Installation of software and computer equipment" funded by European Union structural funds programme "E-business" and administrated by Lithuanian Business Support Agency.
Vittamed Corporation will exhibit at the 2016 AANS meeting in Chicago
Innovators in pediatric care compete for grants
Vittamed secures $10M in venture funding for commercialization of non-invasive Intracranial Pressure (ICP) system
American and German Space Institutes used Vittamed's Non-invasive intracranial pressure meter (Vittamed 205) in Trail Blazing Biomedical Research Study.
Visit us at 1st Congress of the European Academy of Neurology, June 20-23, Berlin, Stand D55.
Visit us at 83th AANS Annual Scientific, May 2-6, 2015, Washington, D.C. Stand 630.
Visit us at Medical World Americas Conference and Expo, April 27-29, 2015, George R. Brown Convention Center, Houston,TX, Stand 425.
Vittamed will participate in one of the biggest Neurosurgery Congresses - 14th Asian Australasian Congress of Neurological Surgeons on 15-18 April, 2015 in South Korea. Visit us at Stand E17.
8 News Now: "Interstellar brain monitoring" - presents Vittamed Non-invasive ICP meter
Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors
Clinical study „Update in intracranial pressure evaluation methods and translaminar pressure gradient role in glaucoma“ was published in the Journal of "Acta Ophthalmologica". Vittamed‘s non-invasive absolute ICP value meter was used as a key technology for this research.
Vittamed Received CE Mark Approval for Non-invasive Intracranial Pressure Meter and Non-invasive Cerebrovascular Autoregulation Monitor.
New clinical study finds Vittamed’s non-invasive Intracranial Pressure measurement technology a significant improvement over existing methods.
Clinical study „The Difference in Translaminar Pressure Gradient and Neuroretinal Rim Area in Glaucoma and Healthy Subjects“ was published in the Journal of the Ophthalmology. Vittamed‘s non-invasive absolute ICP value meter was used as a key technology for this research.
Vittamed's CEO Remis Bistras will present at the IN3 Medical device 360o in Boston on June 19-20, 2014.
Vittamed's CEO Remis Bistras participated at the Neurotech Investing and Partnering Conference in Boston April 23-24, 2014.
Vittamed's CEO Remis Bistras presented at the American Association of Neurological Surgeons (AANS) Annual meeting in San Francisco, April 5-9, 2014.
Vittamed to Present at OneMedForum in San Francisco, January 14, 2014.
Bio-News Texas about Vittamed: NBCM Scientists Research New Non-invasive Intracranial Pressure Measurement Device In Patients And Potentially Astronauts.
Medical Device Daily: NSBRI evaluates use of Vittamed's intracranial pressure monitor.
Press Release: New non-invasive intracranial pressure measurement device used to assess elevated brain pressure in patients may also benefit astronauts. Boston - Dec. 18, 2013.
Vittamed's CEO Remis Bistras will present at the New England Venture Summit in Boston on December 11, 2013.
Vittamed's non-invasive absolute Intracranial Pressure (aICP) value meter, non-invasive cerebrovascular autoregulation monitor and non-invasive intracranial pressure and volume wave monitoring system was presented in 15th International Conference on Intracranial pressure and Brain monitoring, Singapore, 6-10 November 2013.